These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8585027)

  • 1. Acquired activated protein C-resistance in patients with lupus anticoagulants.
    Ehrenforth S; Radtke KP; Scharrer I
    Thromb Haemost; 1995 Aug; 74(2):797-8. PubMed ID: 8585027
    [No Abstract]   [Full Text] [Related]  

  • 2. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interference of factor VIII excess on the detection of lupus anticoagulants by the activated partial thromboplastin time].
    Guermazi S; Gorgi Y; Ayed K; Dellagi K
    Pathol Biol (Paris); 1997 Jan; 45(1):28-33. PubMed ID: 9097843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total knee replacement in a patient with lupus anticoagulant.
    Bhagia UT; Corpe RS; Steflik D
    J South Orthop Assoc; 1997; 6(3):231-4. PubMed ID: 9322205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of lupus anticoagulant on a commercially available kit for APC-resistance.
    Halbmayer WM; Haushofer A; Schön R; Fischer M
    Thromb Haemost; 1994 Oct; 72(4):645-6. PubMed ID: 7878647
    [No Abstract]   [Full Text] [Related]  

  • 7. Lupus anticoagulants.
    Shapiro SS; Thiagarajan P
    Prog Hemost Thromb; 1982; 6():263-85. PubMed ID: 6820164
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of a new commercial dilute prothrombin time in the diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2008; 123(2):404-11. PubMed ID: 18495217
    [No Abstract]   [Full Text] [Related]  

  • 9. The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine.
    Kelsey PR; Stevenson KJ; Poller L
    Thromb Haemost; 1984 Oct; 52(2):172-5. PubMed ID: 6441303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical experience on patients with serum lupus anticoagulants. A report of two cases.
    Minezaki T; Ichikawa Y
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):95-7. PubMed ID: 7701535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated protein C resistance and lupus anticoagulant in pregnancy.
    Busowski JD; Jenkins AD; Hale EU; Busowski M; Dacus JV
    J Matern Fetal Med; 1999; 8(6):298-9. PubMed ID: 10582865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Initial experience in the diagnosis of thrombophilia due to activated protein C resistance].
    Barkagan ZS; Gervaziev VB; Tsyvkina LP; Mamaev AN; Karpenko AA; Tseĭmak IIa
    Ter Arkh; 1997; 69(2):35-7. PubMed ID: 9173574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Presentation of 20 cases of lupus anticoagulant. Proposal for a methodology for its study].
    Mompel Sanjuán A; Abad Gosalbez A; García Pérez A; Marco Vera P
    Sangre (Barc); 1988 Aug; 33(4):306-9. PubMed ID: 3142061
    [No Abstract]   [Full Text] [Related]  

  • 14. Soluble CD154 plasma levels in patients with systemic lupus erythematosus: modulation by antiphospholipid antibodies.
    Ferro D; Pignatelli P; Loffredo L; Conti F; Valesini G; D'Angelo A; Violi F
    Arthritis Rheum; 2004 May; 50(5):1693-4. PubMed ID: 15146442
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged aPTT after kidney transplantation due to transient lupus anticoagulants.
    Nybo M; Dieperink H; Kristensen SR
    Nephrol Dial Transplant; 2006 Apr; 21(4):1060-5. PubMed ID: 16384821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated protein C resistance assay as a screening test for thromboembolic disposition.
    Shizuka R; Amagai H; Kojima J; Fukumura Y; Kanda T; Kobayashi I
    J Med; 1997; 28(5-6):381-6. PubMed ID: 9604796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fatal thrombotic disorder associated with an acquired inhibitor of protein C.
    Mitchell CA; Rowell JA; Hau L; Young JP; Salem HH
    N Engl J Med; 1987 Dec; 317(26):1638-42. PubMed ID: 3683503
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lupus anticoagulant as a risk factor of thrombosis].
    Lewandowski K; Zawilska K
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):154-5. PubMed ID: 1437806
    [No Abstract]   [Full Text] [Related]  

  • 19. [Newly developed method by the use of factor Y assay for the detection of the lupus anticoagulant].
    Amagai H; Shizuka R; Hayakawa M; Kojima J; Fukumura Y; Kobayashi N; Kobayashi I
    Rinsho Byori; 1993 Jun; 41(6):713-8. PubMed ID: 8361039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free protein S deficiency may be found in patients with antiphospholipid antibodies who do not have systemic lupus erythematosus.
    Crowther MA; Johnston M; Weitz J; Ginsberg JS
    Thromb Haemost; 1996 Nov; 76(5):689-91. PubMed ID: 8950774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.